Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.
The very best way to compare one treatment to another is a randomized control trial (RCT), but that is not always possible or every advisable. Match adjusted indirect comparison (MAIC) can offer a scientific way to compare different therapies by using sophisticated statistical methods to match the study populations from different drug trials.
Dr. Mazyar Shadman offers a clear and balanced explanation of the benefits and limitations of MAIC research.
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
One click to our most popular content.
